What is the typical dosage of clindamycin (antibiotic) for adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clindamycin Dosage Guidelines for Adults and Children

The recommended dosage of clindamycin for adults is 150-300 mg orally every 6 hours for serious infections and 300-450 mg every 6 hours for more severe infections, while pediatric dosing is 8-16 mg/kg/day divided into three or four equal doses for serious infections and 16-20 mg/kg/day for more severe infections. 1

Adult Dosing

Oral Administration

  • For serious infections: 150-300 mg every 6 hours 1
  • For more severe infections: 300-450 mg every 6 hours 1
  • For skin and soft tissue infections: 300-450 mg four times daily 2

Intravenous Administration

  • For skin and soft tissue infections: 600 mg every 8 hours 2
  • For severe infections: 600-900 mg every 6-8 hours 2
  • For pelvic inflammatory disease: 900 mg every 8 hours (typically with gentamicin) 2

Pediatric Dosing

Oral Administration

  • For serious infections: 8-16 mg/kg/day divided into three or four equal doses 1
  • For more severe infections: 16-20 mg/kg/day divided into three or four equal doses 1
  • For MRSA infections: 30-40 mg/kg/day divided into 3-4 doses 3, 4
  • For Group A Streptococcal infections: 40 mg/kg/day in 3 doses 4

Intravenous Administration

  • For MRSA infections: 40 mg/kg/day divided every 6-8 hours 3, 2
  • For pneumonia: 10-13 mg/kg/dose every 6-8 hours, not to exceed 40 mg/kg/day 3
  • For Group A Streptococcal infections: 7-10 mg/kg every 6-8 hours (up to a maximum of 600 mg per dose) 3

Special Considerations

Duration of Therapy

  • For β-hemolytic streptococcal infections: at least 10 days 1
  • For skin and soft tissue infections: 7-14 days depending on clinical response 2
  • Intravenous therapy should continue for at least 48 hours after clinical improvement before transitioning to oral therapy 2

Administration Guidelines

  • Oral clindamycin should be taken with a full glass of water to avoid esophageal irritation 1
  • For children who cannot swallow capsules, clindamycin palmitate oral solution should be used 1
  • Clindamycin should be dosed based on total body weight regardless of obesity 1

Combination Therapy

  • For babesiosis: Clindamycin (300-600 mg every 6-8 hours IV or 600 mg every 8 hours orally for adults; 7-10 mg/kg every 6-8 hours for children) plus quinine (650 mg every 6-8 hours orally for adults; 8 mg/kg every 8 hours for children) 3

Important Cautions

  • If significant diarrhea occurs during therapy, clindamycin should be discontinued 1
  • Higher doses (600 mg) are associated with increased frequency and severity of gastrointestinal side effects compared to lower doses (300 mg) 5
  • Almost all patients (98%) may experience some side effects from oral clindamycin, with higher doses causing more prolonged symptoms 5

Pathogen-Specific Considerations

  • For methicillin-resistant Staphylococcus aureus (MRSA) infections susceptible to clindamycin, oral dosing should be 30-40 mg/kg/day in 3-4 doses for children 3
  • For methicillin-susceptible Staphylococcus aureus infections in children, oral clindamycin should be given at 30-40 mg/kg/day in 3-4 doses 2

This dosing information provides a comprehensive guide for clinicians prescribing clindamycin for various infections in both adult and pediatric populations, with specific considerations for route of administration, severity of infection, and pathogen susceptibility.

References

Guideline

Clindamycin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clindamycin Dosing for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.